Phase III trial of bolus 5-fluorouracil (5-FU)/folinic acid (FA) (MAYO) vs. weekly oxaliplatin (OXA) plus high dose 24h 5-FU infusion/FA in patients with advanced colorectal cancer (CRC)

作者： A. Grothey , T. Buechele , H. Kroening , K. Ridwelski , P. Reichardt

DOI: 10.1016/S0959-8049(01)81446-5

关键词: Fluorouracil 、 Oncology 、 Oxaliplatin 、 Advanced colorectal cancer 、 Gastroenterology 、 Internal medicine 、 Medicine 、 Folinic acid 、 Bolus (medicine) 、 In patient